Benign neoplasm: Stomach

CD2_BENIGN_STOMACH_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D13.1& Hospital discharge: ICD-9 — 2111 Hospital discharge: ICD-8 — 2111 Cause of death: ICD-10 — D13.1& Cause of death: ICD-9 — 2111 Cause of death: ICD-8 — 2111 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D13
Name in latin: Neoplasma benignum ventriculi

NAME	CD2_BENIGN_STOMACH_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D131
HD_ICD_9	2111
HD_ICD_8	2111
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D131
COD_ICD_9	2111
COD_ICD_8	2111
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Stomach based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Stomach

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3700	2383	1317
Unadjusted period prevalence (%)	0.73	0.81	0.58
Median age at first event (years)	64.38	62.96	66.95

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3330: Matched controls
33300

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

4503599627370496.0

323.0

3253

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

23.7

323.0

2834

6470

UJF32

NOMESCO Finland

Coloscopy

4.1

281.8

1502

5562

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

147.7

269.3

284

130

Kela drug reimbursment

Malignant tumour

+∞

217.1

206

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

90.1

182.6

203

115

Kela drug reimbursment

Breast cancer

+∞

180.9

172

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

5.0

177.3

633

1479

C61

ICD-10 Finland

Malignant neoplasm of prostate

456.0

175.6

174

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

173.4

165

A02BC02

ATC

pantoprazole; systemic

3.0

167.9

2537

17246

A02BC05

ATC

esomeprazole; systemic

2.8

167.7

1819

10076

PJA12

NOMESCO Finland

Sentinel node biopsy

408.8

157.7

157

A03FA01

ATC

metoclopramide; systemic, rectal

3.8

155.2

758

2371

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

4.0

145.5

677

2017

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

140.6

134

H02AB02

ATC

dexamethasone; systemic

17.1

139.1

226

141

JN4BD

NOMESCO Finland

Extensive body CT

6.1

134.0

392

710

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

131.1

125

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.8

130.3

620

1868

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

66.3

120.9

140

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.5

120.1

467

1160

A02BC03

ATC

lansoprazole; oral

2.4

116.0

1346

7230

K29.4

ICD-10 Finland

Chronic atrophic gastritis

8.7

113.8

256

314

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

92.0

111.9

124

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

28.6

111.4

153

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

111.0

1661

10060

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

16.6

105.0

172

109

A04AA02

ATC

granisetron; systemic, transdermal

116.9

104.6

113

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.5

101.0

1045

5193

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

100.4

1355

7694

B03BA03

ATC

hydroxocobalamin; parenteral

4.4

96.2

378

939

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

933.8

93.3

116

Kela drug reimbursment

Prostate cancer

+∞

92.1

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

912.6

91.2

D64.9

ICD-10 Finland

Anaemia, unspecified

3.3

90.0

508

1713

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

3.0

87.0

565

2099

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.7

86.9

412

1209

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

859.9

86.0

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

19.8

82.3

126

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

81.7

548

2075

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

4.4

81.4

317

776

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.4

81.1

849

4162

JN4AD

NOMESCO Finland

Body CT examination

5.8

80.9

242

443

B01AB05

ATC

enoxaparin; parenteral

2.2

80.4

1108

6187

HAC20

NOMESCO Finland

Total mastectomy

77.2

79.5

107

Kela drug reimbursment

Pernicious anaemia

8.0

78.3

185

244

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

77.4

L02BG04

ATC

letrozole; oral

29.2

77.2

105

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.1

77.2

474

1686

UJD02

NOMESCO Finland

Gastroscopy

4.2

75.7

310

795

UJF30

NOMESCO Finland

Ileoscopy through colon

3.1

73.8

457

1633

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

255.7

73.7

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

73.2

709

3315

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

71.3

1026

5774

A02BC01

ATC

omeprazole; systemic

2.1

71.1

1132

6645

L03AA13

ATC

pegfilgrastim; parenteral

702.6

70.3

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

69.8

1383

8833

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

69.0

L02BA01

ATC

tamoxifen; oral

59.2

69.0

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

68.9

1221

7458

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

67.7

778

3940

B81

ICPC

Anaemia vit B12/folate deficiency

4.5

67.6

256

607

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

67.3

861

4576

A04AA01

ATC

ondansetron; systemic, rectal

6.4

67.2

184

300

K30

ICD-10 Finland

Functional dyspepsia

2.7

67.0

502

2021

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

64.8

L01BC06

ATC

capecitabine; oral

+∞

64.8

HAB40

NOMESCO Finland

Wedge excision of mammary gland

20.2

64.7

ZX120

NOMESCO Finland

Intravenous

3.4

64.0

336

1059

WF002

NOMESCO Finland

Radical radiotherapy

33.1

63.8

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

63.6

683

3334

N02BE01

ATC

paracetamol; systemic, rectal

2.3

62.8

2897

24854

HA1AA

NOMESCO Finland

X-ray mammography

5.1

62.7

209

433

Z2221

NOMESCO Finland

Medical doctor

2.0

61.9

992

5765

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

61.6

ZX090

NOMESCO Finland

Other technic of radiotherapy

163.0

61.1

WX002

NOMESCO Finland

Sedation and analgesia

2.2

60.8

795

4237

A02BA02

ATC

ranitidine; systemic

2.1

60.7

835

4552

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

60.3

1247

7969

JDA63

NOMESCO Finland

Local excision of lesion of stomach

130.4

60.0

C50.99

ICD-10 Finland

Breast, unspecified

+∞

56.4

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

56.4

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.6

55.5

169

315

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.3

54.5

215

529

R4110

NOMESCO Finland

Physiotherapy

2.0

53.9

903

5285

L03AA02

ATC

filgrastim; parenteral

53.4

52.9

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

18.8

52.4

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

51.5

851

4939

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.5

51.5

253

754

N02AX02

ATC

tramadol; systemic, rectal

1.8

50.9

1449

10128

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

50.1

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

50.0

1039

6539

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

59.0

49.5

WF049

NOMESCO Finland

Radiotherapy of metastasis

495.0

49.5

A04AA55

ATC

palonosetron, combinations; systemic

+∞

48.0

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.5

47.1

174

401

R06.0

ICD-10 Finland

Dyspnoea

1.9

46.8

924

5689

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

464.0

46.4

C50

ICD-10 Finland

Malignant neoplasm of breast

+∞

45.9

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.9

45.6

154

323

Z3226

NOMESCO Finland

Physiotherapist

2.0

45.4

652

3556

UJF92

NOMESCO Finland

Capsular endoscopy

6.0

44.9

128

220

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

49.8

44.9

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

44.9

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

6.4

44.4

121

196

WF003

NOMESCO Finland

Adjuvant radiotherapy

64.7

44.2

8936/1-C16.9

ICD-O-3

Gastrointestinal stromal tumor, NOS, of stomach, NOS

227.9

44.0

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

433.1

43.3

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

44.8

43.2

J01MA02

ATC

ciprofloxacin; systemic

1.7

42.0

1272

8893

A02BC04

ATC

rabeprazole; oral

2.5

42.0

374

1633

XX3DW

NOMESCO Finland

Time consuming IT work

3.3

41.5

222

705

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

14.3

40.9

21110

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Stomach

+∞

40.7

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

40.7

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

4.0

40.5

169

438

Z51.5

ICD-10 Finland

Palliative care

5.0

40.0

134

279

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

39.9

196

583

Z3231

NOMESCO Finland

Registered nurse

1.8

39.5

875

5541

J02AC01

ATC

fluconazole; systemic

1.7

39.3

1310

9360

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

391.9

39.1

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

39.1

347

1510

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

17.1

38.9

R03AC02

ATC

salbutamol; inhalant

1.6

38.9

1697

13020

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

16.0

38.6

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.6

38.5

306

1254

ZXE20

NOMESCO Finland

More than three and less than five hours

2.2

38.4

451

2248

D13.0

ICD-10 Finland

Benign neoplasm: Oesophagus

21.9

38.3

JN4CD

NOMESCO Finland

Very extensive body CT

5.9

38.1

110

193

K29.7

ICD-10 Finland

Gastritis, unspecified

3.5

37.6

182

535

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

37.6

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

37.6

SPAT1263

SPAT

Sampling

1.6

37.5

1403

10296

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

5.7

37.4

110

197

N03AX16

ATC

pregabalin; oral

1.8

37.2

821

5176

JDA45

NOMESCO Finland

Endoscopic mucosal or submucosal resection in stomach or pylorus

371.3

37.1

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

371.3

37.1

WW500

NOMESCO Finland

Blood transfusion

4.9

37.0

125

263

WX402

NOMESCO Finland

General anaesthesia

2.1

36.9

453

2300

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

83.1

36.9

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

3.9

36.8

160

430

K92.1

ICD-10 Finland

Melaena

3.0

36.7

227

797

R13

ICD-10 Finland

Dysphagia

2.6

36.7

278

1108

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

36.5

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

36.5

L02AE02

ATC

leuprorelin; implant, parenteral

12.0

35.8

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.2

35.7

386

1849

K22.1

ICD-10 Finland

Ulcer of oesophagus

5.1

35.6

116

235

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

35.0

545

3034

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

12.6

35.0

N02AA05

ATC

oxycodone; systemic

2.1

34.9

416

2080

J01DB01

ATC

cefalexin; oral

1.7

34.7

2583

22415

C03CA01

ATC

furosemide; systemic

1.7

34.6

1010

6888

NK6AN

NOMESCO Finland

Total body bone isotope imaging

22.6

33.9

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

33.7

642

3837

WX110

NOMESCO Finland

Local anesthesy

1.6

33.6

2045

16763

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

33.4

R01AD09

ATC

mometasone; nasal

1.6

33.2

1398

10470

R4190

NOMESCO Finland

Nutritional therapy

4.9

32.9

110

229

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.2

32.7

177

567

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.4

32.2

295

1301

K22.7

ICD-10 Finland

Barrett oesophagus

6.3

32.1

141

B01AB10

ATC

tinzaparin; parenteral

3.0

32.1

195

677

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

166.6

31.7

AA1AD

NOMESCO Finland

CT of head and brain

1.7

31.6

837

5530

ZXE00

NOMESCO Finland

One hour or less

1.6

31.4

1205

8784

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

5.2

31.3

100

198

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

31.3

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.3

31.3

315

1454

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

3.3

31.2

165

519

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.4

31.2

158

481

XW000

NOMESCO Finland

Bone marrow biopsy

3.8

31.2

136

367

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

31.1

252

1041

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

31.1

653

4017

A04AD12

ATC

aprepitant; systemic

161.5

30.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

30.7

1421

10820

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

30.5

260

1105

C07AB07

ATC

bisoprolol; oral

1.5

30.4

1646

12979

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.0

30.4

432

2315

H02AB06

ATC

prednisolone; systemic

1.5

30.4

1505

11630

L02BB03

ATC

bicalutamide; oral

+∞

30.2

N06AX11

ATC

mirtazapine; oral

1.6

30.0

1021

7200

GD1AD

NOMESCO Finland

Thorax CT examination

3.4

30.0

153

469

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

29.9

2015

16674

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

5.2

29.5

186

XKD00

NOMESCO Finland

Uroflowmetry

2.0

29.4

426

2297

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

3.1

29.4

173

586

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

50.5

29.4

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

29.2

323

1557

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

17.3

29.2

189

Kela drug reimbursment

Imatinib

+∞

29.2

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

29.2

A03FA02

ATC

cisapride; oral, rectal

2.2

28.9

323

1564

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

294.4

28.8

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

294.4

28.8

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

294.4

28.8

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

28.5

184

663

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.8

28.5

207

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

4.0

28.4

118

305

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

16.9

28.4

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.8

28.2

191

710

8240/3-C16.9

ICD-O-3

Neuroendocrine tumor, NOS, of stomach, NOS

+∞

28.2

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.7

27.9

197

750

R50.9

ICD-10 Finland

Fever, unspecified

2.0

27.9

397

2127

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

100.9

27.7

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.6

27.4

147

R11

ICD-10 Finland

Nausea and vomiting

2.3

27.3

276

1274

UKC02

NOMESCO Finland

Cystoscopy

1.9

27.3

480

2776

D02

ICPC

Abdominal pain epigastric

2.5

27.3

218

894

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.4

27.1

134

401

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

27.1

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

27.1

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

27.1

1348

10337

Y77

ICPC

Malignant neoplasm prostate

97.5

26.7

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.7

26.5

120

335

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.8

26.4

114

306

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

26.1

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

26.1

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

25.9

505

3018

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

73.2

25.8

R12

ICD-10 Finland

Heartburn

2.3

25.8

261

1207

C03DA01

ATC

spironolactone; oral

1.9

25.7

393

2158

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

18.8

25.6

A07AA02

ATC

nystatin; oral

2.3

25.1

236

1051

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.8

25.0

164

597

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

25.0

L01XE01

ATC

[U] imatinib; oral

+∞

25.0

E0000UV

ATC

1.5

25.0

1190

8989

D51.0

ICD-10 Finland

Vitamin B12deficiency anaemia due to intrinsic factor deficiency

7.3

24.7

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

252.0

24.7

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

252.0

24.7

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

252.0

24.7

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

24.4

469

2784

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

24.4

472

2808

R53

ICD-10 Finland

Malaise and fatigue

1.7

24.3

657

4316

L02BG03

ATC

anastrozole; oral

48.7

24.3

S18

ICPC

Laceration/cut

1.5

24.1

1265

9734

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

24.0

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

24.0

J01MA12

ATC

levofloxacin; systemic

1.7

23.7

549

3454

D01

ICPC

Abdominal pain/cramps general

2.0

23.7

337

1799

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

23.6

362

1989

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

23.5

717

4860

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

23.8

23.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

23.4

1179

8977

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

23.3

278

1381

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

23.2

1120

8449

R51.80

ICD-10 Finland

Headache

1.8

23.0

440

2603

G44.2

ICD-10 Finland

Tension-type headache

1.8

23.0

431

2535

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

22.9

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

22.9

C16.00

ICD-10 Finland

Cardia

+∞

22.9

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

22.9

N05CF01

ATC

zopiclone; oral

1.5

22.9

1030

7647

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

22.8

635

4200

R03DC03

ATC

montelukast; oral

1.7

22.8

522

3265

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

5.1

22.7

147

TQW20

NOMESCO Finland

Tatoe

84.0

22.7

Z2446

NOMESCO Finland

Social worker

2.4

22.7

196

839

E66.8

ICD-10 Finland

Other obesity

2.5

22.6

181

743

WX892

NOMESCO Finland

Monitored bed care

2.2

22.6

249

1196

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

120.8

22.6

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

120.8

22.6

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

6.6

22.5

M54.5

ICD-10 Finland

Low back pain

1.5

22.5

1002

7416

R18

ICD-10 Finland

Ascites

5.9

22.3

109

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

22.3

242

1154

ICD-10 Finland

3.3

22.3

114

352

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.9

22.2

244

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.5

22.1

107

316

N03AX12

ATC

gabapentin; oral

1.7

22.0

524

3317

J01CA04

ATC

amoxicillin; systemic

1.5

22.0

2456

21796

L57.0

ICD-10 Finland

Actinic keratosis

2.1

21.9

275

1396

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

21.9

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

21.9

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

21.9

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

21.9

8240/3-C16.2

ICD-O-3

Neuroendocrine tumor, NOS, of body of stomach

+∞

21.9

A06AD11

ATC

lactulose; oral

1.7

21.9

455

2765

JAH01

NOMESCO Finland

Laparoscopy

2.7

21.8

149

558

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

21.7

507

3191

C90.0

ICD-10 Finland

Multiple myeloma

221.3

21.6

H02AB07

ATC

prednisone; oral

1.7

21.5

469

2893

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

31.3

21.5

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.9

21.4

144

SPAT1312

SPAT

General health counselling

1.5

21.3

962

7123

M79.6

ICD-10 Finland

Pain in limb

1.5

21.2

1152

8864

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

50.3

21.1

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

9.9

21.0

G47.3

ICD-10 Finland

Sleep apnoea

1.6

20.9

648

4394

R05

ICD-10 Finland

Cough

1.6

20.9

621

4164

ZXD05

NOMESCO Finland

Urgent procedure

1.5

20.9

885

6458

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

20.8

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

20.8

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

20.8

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

20.8

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

20.8

159

636

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

20.8

269

1381

ZXA05

NOMESCO Finland

Left side

1.5

20.8

810

5798

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

5.2

20.7

128

ZXA00

NOMESCO Finland

Right side

1.5

20.7

862

6266

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

77.3

20.7

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

20.7

334

1864

SPAT1254

SPAT

Administration of medicine

1.7

20.6

464

2881

SPAT1255

SPAT

Intravenous administration of medicine

2.2

20.6

219

1036

X76

ICPC

Malignant neoplasm breast female

211.2

20.6

J01AA02

ATC

doxycycline; systemic

1.5

20.5

2503

22406

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

20.4

274

1427

SPAT1301

SPAT

No procedures

1.5

20.4

1005

7565

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

7.0

20.4

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

20.3

519

3343

J01FA06

ATC

roxithromycin; oral

1.4

20.2

1269

10015

J45

ICD-10 Finland

Asthma

1.9

20.2

330

1850

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.4

20.1

100

303

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

20.0

380

2237

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.3

19.9

181

795

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

4.5

19.9

161

128

Kela drug reimbursment

Cancers of female genital organs

+∞

19.8

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

19.8

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

19.8

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

19.8

TQW99

NOMESCO Finland

Other minor procedure on skin

2.8

19.8

133

493

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

19.6

248

1263

N05BA04

ATC

oxazepam; oral

1.5

19.6

745

5296

XF404

NOMESCO Finland

Ambulatory ECG

1.9

19.6

316

1764

R01AD08

ATC

fluticasone; nasal

1.5

19.5

843

6160

C08CA01

ATC

amlodipine; oral

1.4

19.5

1182

9250

R03BA02

ATC

budesonide; inhalant

1.6

19.5

556

3683

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

19.4

298

1633

Z01.7

ICD-10 Finland

Laboratory examination

1.8

19.4

359

2096

Z31.5

ICD-10 Finland

Genetic counselling

3.1

19.3

106

345

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.4

19.3

174

760

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

19.2

524

3429

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

46.3

19.2

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

19.1

1602

13282

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

19.1

327

1864

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

19.0

550

3656

K92.0

ICD-10 Finland

Haematemesis

3.4

19.0

279

ZZR00

NOMESCO Finland

Flap of skin

8.2

18.9

SPAT1153

SPAT

Removal of sutures

1.5

18.9

960

7246

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

14.9

18.9

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

6.0

18.9

XJH00

NOMESCO Finland

Transanal ultrasonography

2.4

18.8

162

692

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

18.8

220

1085

JDW97

NOMESCO Finland

Other laparoscopic operation on stomach or duodenum

+∞

18.8

2111X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Stomach[NEOPLASMA BENIGNUM ALIUD VENTRICULI]

+∞

18.8

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

18.8

UJH02

NOMESCO Finland

Anoscopy

2.5

18.7

152

629

ZX080

NOMESCO Finland

Image guided radiotherapy

70.3

18.7

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

70.3

18.7

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

38.6

18.5

A79

ICPC

Malignancy NOS

38.6

18.5

3AC01

NOMESCO Finland

5.6

18.5

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

18.5

1440

11761

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

18.5

255

1343

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

18.4

122

450

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

18.4

581

3946

B82

ICPC

Anaemia other/unspecified

3.2

18.2

304

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.8

18.2

303

1709

N06AX16

ATC

venlafaxine; oral

1.7

18.1

376

2278

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

18.0

201

971

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

17.9

202

979

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.0

17.9

106

364

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

17.8

166

737

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

17.8

194

928

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

17.8

201

977

R03AC03

ATC

terbutaline; inhalant

1.6

17.7

447

2861

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

17.7

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

17.7

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

17.7

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

17.7

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

17.7

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

17.7

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

17.7

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

17.7

214

1071

P01AB01

ATC

metronidazole; oral, rectal

1.4

17.7

1189

9441

WF004

NOMESCO Finland

Palliative radiotherapy

95.5

17.6

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

180.9

17.5

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

180.9

17.5

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

17.5

1079

8427

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

4.1

17.4

169

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

17.4

163

726

R31

ICD-10 Finland

Unspecified haematuria

1.9

17.3

268

1473

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

17.3

171

782

ZX112

NOMESCO Finland

Subcutaneous

6.4

17.3

J01FA10

ATC

azithromycin; systemic

1.4

17.3

1659

13981

M05BX04

ATC

denosumab; parenteral

2.4

17.3

150

645

R06AE07

ATC

cetirizine; oral

1.4

17.2

1265

10186

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.1

17.2

204

1011

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

17.2

417

2642

C10AC01

ATC

colestyramine; oral

2.9

17.1

105

370

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.4

17.0

144

611

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768797) Stomach Pathology biopsy report

1591

4222

5.86

307.65

1.7

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2503

14346

3.30

252.41

7.4

3.7

umol/l

11.4

11.5

0.14

2368

13370

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

615

1611

4.38

213.68

3.3

1.4

ug/l

4.3

11.2

0.45

490

1205

(3024561) Albumin [Mass/volume] in Serum or Plasma

2204

12485

2.89

212.53

6.3

3.7

g/l

35.4

35.7

1.69

2054

11371

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1578

7622

2.87

204.27

3.4

2.3

mg/l

3.5

2.9

11.25

1373

6454

(4035726)

433

892

5.37

201.17

1.5

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2095

12300

2.62

175.96

4.5

2.8

ug/l

107.5

121.5

1.88

1948

11261

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3142

22870

3.48

170.43

10.3

5.4

u/l

82.1

76.5

6.35

2997

21096

(3013650) Neutrophils [#/volume] in Blood by Automated count

2471

15913

2.66

168.04

10.6

6.4

e9/l

4.1

4.2

1.95

2203

13628

(3001604) Monocytes [#/volume] in Blood

2271

14436

2.48

152.26

7.4

5.4

e9/l

0.6

1.86

2007

12343

(3006315) Basophils [#/volume] in Blood

2277

14530

2.47

150.75

7.5

5.4

e9/l

0.0

0.01

2015

12424

(3019198) Lymphocytes [#/volume] in Blood

2299

14814

2.46

147.68

7.5

5.5

e9/l

1.8

1.9

2.05

2063

12894

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1683

9459

2.43

147.10

3.3

2.3

u/l

55.9

58.6

2.01

1560

8608

(3013115) Eosinophils [#/volume] in Blood

2319

15035

2.45

146.39

7.8

5.5

e9/l

0.2

1.84

2089

13074

(3022948) Iron [Moles/volume] in Serum or Plasma

1024

4610

2.69

143.02

3.3

2.5

umol/l

11.5

13.0

10.03

947

4218

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2155

13668

2.38

140.80

2.5

2.0

pmol/l

93.7

96.0

1.03

1163

6710

(40768804) Tissue Pathology biopsy report

1728

10017

2.36

138.38

2.4

1.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2294

15154

2.35

133.36

8.6

5.5

mmol/l

1.2

5.77

2008

12666

(3027945) Reticulocytes/100 erythrocytes in Blood

800

3283

2.83

132.71

2.5

2.1

1.8

0.29

702

2856

(3004789) Transferrin [Mass/volume] in Serum or Plasma

935

4200

2.64

129.56

3.3

2.5

g/l

2.4

2.3

4.10

871

3855

(3015377) Calcium [Moles/volume] in Serum or Plasma

1666

9735

2.29

128.16

3.7

2.1

mmol/l

2.3

2.4

4.21

1432

8100

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

281

584

5.12

127.95

3.4

1.8

u/ml

2391.0

77.1

0.51

233

464

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

606

2180

3.13

127.08

2.8

2.0

g/l

0.2

1.82

560

1967

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2110

13643

2.27

126.35

7.8

5.1

mmol/l

1.2

6.22

1942

12029

(40758558) Short blood count panel - Blood

1271

6679

2.38

124.72

8.4

4.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

878

3893

2.65

124.33

3.4

2.6

19.5

22.5

8.56

755

3247

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

699

2769

2.88

123.11

4.6

2.8

u/l

234.2

238.0

0.37

648

2570

(3032080) INR in Blood by Coagulation assay

1929

12188

2.22

120.07

10.8

9.9

inr

1.3

0.51

388

3465

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

719

2999

2.73

114.06

3.2

2.2

umol/l

8.4

7.8

0.25

628

2549

(3033658) Prothrombin time (PT) actual/Normal

1268

6904

2.27

112.16

5.5

3.4

88.7

89.2

0.24

1240

6709

(3022145) Colonoscopy Study observation

727

3104

2.67

109.76

1.4

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1193

6403

2.27

108.60

1.9

1.8

nmol/l

1218.0

1178.0

0.64

927

4777

(3031040) Bacteria [#/volume] in Urine by Automated count

2696

20021

2.28

105.44

6.5

4.6

e6/l

82.5

2673.9

4.96

275

(42870588) Differential panel, method unspecified - Blood

1592

9704

2.12

104.07

7.1

5.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1917

12594

2.08

101.83

4.7

3.6

—

(3018418) pH of Serum or Plasma

1480

8836

2.12

101.54

5.3

3.3

7.4

0.47

171

1538

(3012095) Magnesium [Moles/volume] in Serum or Plasma

880

4253

2.40

101.28

3.7

2.5

mmol/l

0.8

2.16

822

3892

(3044640) Blood type and Crossmatch panel - Blood

1401

8251

2.12

99.05

2.9

2.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

607

2485

2.73

98.81

3.0

2.1

u/l

48.0

55.8

0.12

519

2097

(3013707) Erythrocyte sedimentation rate by Westergren method

2961

23136

2.40

98.46

5.4

4.2

mm/h

14.0

12.5

6.08

2755

21286

(3014576) Chloride [Moles/volume] in Serum or Plasma

745

3432

2.47

94.69

7.9

6.3

mmol/l

104.1

0.06

735

3350

(3006504) Eosinophils/100 leukocytes in Blood

1967

13390

2.00

90.81

7.8

5.7

2.9

3.0

0.47

1835

12303

(3019069) Monocytes/100 leukocytes in Blood

1972

13450

2.00

90.37

8.2

5.9

8.7

0.27

1839

12416

(3023520) Reticulocytes [#/volume] in Blood

590

2483

2.64

90.36

2.4

2.2

e9/l

69.5

69.3

0.06

459

1876

(3002030) Lymphocytes/100 leukocytes in Blood

1999

13753

1.99

88.73

8.0

5.8

26.7

27.7

3.97

1856

12609

(3022096) Basophils/100 leukocytes in Blood

1916

13000

1.98

88.44

7.8

5.7

0.7

0.62

1787

11947

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

123

162

7.82

88.02

3.4

1.6

nmol/l

13.6

4.1

1.52

115

153

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1021

5542

2.16

87.15

3.4

2.2

mmol/l

2.4

2.5

0.58

893

4751

(3013826) Glucose [Moles/volume] in Serum or Plasma

2402

17761

2.00

84.86

6.4

4.2

mmol/l

6.8

0.32

2284

16559

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1120

6353

2.09

84.82

1.3

1.2

u/ml

1.7

1.8

0.11

291

1661

(36304419) Bacteria [Presence] in Urine

1293

7752

2.03

83.97

3.9

2.9

—

(3018010) Neutrophils/100 leukocytes in Blood

1968

13645

1.94

83.42

7.8

5.6

58.2

57.5

1.88

1827

12575

(3030467) Casts [#/volume] in Urine by Automated count

1317

7999

2.00

82.04

4.1

3.0

e6/l

0.5

0.4

0.18

1048

5937

(3003458) Phosphate [Moles/volume] in Serum or Plasma

746

3656

2.30

81.19

6.6

5.1

mmol/l

1.0

0.10

699

3345

(3037467) Urinalysis macro (dipstick) panel - Urine

2699

21007

2.05

79.76

6.1

4.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1275

7719

1.99

79.65

1.8

1.5

nmol/l

21.5

20.9

0.47

1118

6458

(3011397) Hemoglobin [Presence] in Urine by Test strip

1232

7386

2.00

79.02

5.4

3.8

—

(3002256) Pathology report gross observation

548

2366

2.54

78.93

1.4

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

914

4929

2.13

78.12

3.2

2.6

e6/l

1.0

1.3

1.98

571

2817

(3018095) Leukocytes [#/volume] in Urine

1573

10279

1.92

78.02

5.0

3.5

e6/l

77.5

114.8

0.68

1168

7113

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

371

1320

3.01

77.55

1.8

1.5

g/l

1.6

1.5

0.12

310

1126

(3048689) Calprotectin [Mass/mass] in Stool

702

3437

2.29

76.11

2.2

2.1

ug/g

132.2

144.0

0.48

551

2664

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1089

6341

2.02

75.17

2.8

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

958

5356

2.06

73.80

1.5

1.3

g/l

2.5

0.26

534

3062

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1402

9004

1.90

71.74

3.9

2.6

u/l

33.1

35.0

0.39

1326

8482

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

805

4255

2.14

71.73

12.5

6.7

—

(3023368) Bacteria identified in Blood by Culture

1211

7423

1.94

71.32

5.0

3.8

—

(3000850) Epithelial cells [#/volume] in Urine

1040

6083

1.99

70.04

3.1

2.5

e6/l

4.8

5.7

2.15

899

5246

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3429

30099

2.90

65.72

23.3

12.9

mg/l

23.1

22.8

0.25

2894

23427

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

456

1980

2.49

64.17

1.8

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

1331

8653

1.84

63.68

4.3

3.0

e6/l

79.6

76.5

0.04

1066

6519

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1822

13108

1.77

61.22

2.8

2.2

nmol/l

79.6

79.3

0.17

1597

11507

(3044889) 12 lead EKG panel

2712

21939

1.88

61.16

5.3

3.9

—

(3009261) Glucose [Presence] in Urine by Test strip

2042

15221

1.76

60.23

5.4

3.8

estimate

0.0

1.32

230

2503

(3026782) Osmolality of Urine

937

5526

1.93

60.17

3.5

2.6

mosm/kgh2o

520.3

536.0

1.43

765

4596

(3035350) Ketones [Presence] in Urine by Test strip

2014

14992

1.75

59.32

5.4

3.8

estimate

0.0

0.00

223

2559

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

415

1787

2.49

59.26

2.7

2.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

2017

15042

1.75

58.81

7.0

5.0

estimate

0.0

0.80

239

2565

(3003396) Base excess in Arterial blood by calculation

626

3231

2.13

58.16

7.7

6.7

mmol/l

1.4

0.05

513

2490

(3027801) Oxygen [Partial pressure] in Arterial blood

629

3255

2.12

58.03

7.7

6.7

kpa

12.0

11.7

0.74

602

3093

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

629

3257

2.12

57.93

7.7

6.7

kpa

5.0

5.1

1.01

602

3104

(3018677) aPTT in Platelet poor plasma by Coagulation assay

796

4499

1.98

57.60

3.0

1.9

30.0

29.8

0.55

771

4354

(40761535) Cells panel - Urine sediment

553

2730

2.21

57.49

4.9

3.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

593

3011

2.15

57.42

2.9

2.4

ug/l

5.3

7.3

2.26

519

2590

(3002173) Hemoglobin [Mass/volume] in Arterial blood

537

2642

2.21

56.22

8.3

7.5

g/l

117.3

121.9

6.17

522

2534

(3000991) Gas panel - Venous blood

475

2238

2.29

55.17

9.6

7.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

778

4440

1.95

54.37

3.7

2.7

e6/l

2.6

3.1

0.58

443

2348

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1427

9821

1.74

53.97

3.8

3.0

ng/l

1395.8

1420.8

0.09

1230

8413

(3019150) Specific gravity of Urine by Refractometry

1079

6852

1.81

53.88

6.3

4.3

kg/l

1.0

0.36

141

1035

(3026008) Bacteria identified in Urine by Culture

1415

9740

1.73

53.31

3.9

3.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

502

2460

2.20

52.88

2.6

1.6

g/l

65.5

66.8

3.04

449

2172

(3014765) Yersinia sp identified in Stool by Organism specific culture

246

858

3.00

52.82

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

244

852

3.00

52.28

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

246

864

2.98

52.16

1.3

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

287

1096

2.75

52.12

1.8

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

504

2495

2.18

51.69

4.0

3.5

ng/l

95.5

91.0

0.46

439

2100

(3020779) Urea [Moles/volume] in Serum or Plasma

490

2404

2.20

51.38

9.6

7.0

mmol/l

10.7

10.6

0.03

467

2274

(3014111) Lactate [Moles/volume] in Serum or Plasma

492

2421

2.19

51.20

8.1

6.4

mmol/l

1.3

1.4

0.34

468

2342

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2862

24065

1.84

50.60

5.2

4.1

pmol/l

14.9

0.04

2632

21686

(3021589) Normoblasts [#/volume] in Blood

1744

12829

1.68

50.51

11.7

8.5

e9/l

0.0

0.52

1464

10478

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1027

6530

1.79

50.49

2.4

1.7

mg/l

1.1

1.2

0.12

796

4983

(3016502) Oxygen saturation in Arterial blood

558

2909

2.08

49.92

8.2

7.0

95.9

95.2

1.79

544

2787

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

980

6216

1.78

48.21

4.7

3.8

ng/l

333.5

425.8

0.32

795

5001

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

488

2455

2.14

47.83

3.2

2.3

ml/min/173m2

62.0

64.0

0.27

206

971

(3007853) Bacteria identified in Skin by Aerobe culture

606

3310

1.99

47.48

1.9

1.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

240

876

2.86

47.39

1.5

1.4

ug/g

254.9

297.1

2.59

139

528

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2335

18707

1.67

47.21

4.0

3.0

u/l

57.6

46.1

5.03

2160

17093

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1676

12345

1.65

47.20

4.7

3.8

ng/l

31.1

56.4

2.98

1183

8714

(3005719) IgG [Mass/volume] in Serum or Plasma

409

1932

2.26

46.86

3.0

2.3

g/l

10.3

10.8

1.61

378

1762

(3013139) Helicobacter pylori Ag [Presence] in Stool

442

2160

2.19

46.57

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1432

10182

1.66

45.94

2.4

2.1

u/l

150.2

207.0

3.29

1357

9471

(40761511) CBC panel - Blood by Automated count

3456

31347

2.55

45.56

21.9

12.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1191

8095

1.69

45.22

3.4

2.4

umol/l

3532.0

5879.5

1.36

1007

6858

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

590

3264

1.96

44.31

2.0

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

458

2323

2.11

43.73

1.6

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

3070

26757

1.87

43.50

26.1

14.3

38.2

39.3

7.79

1961

17805

(3019550) Sodium [Moles/volume] in Serum or Plasma

3491

31924

2.66

43.19

27.4

15.4

mmol/l

139.6

139.8

4.59

3427

31061

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

129

344

3.85

42.32

2.4

1.9

u/ml

2745.3

77.5

0.49

115

315

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3223

28621

1.98

41.93

6.5

4.9

mu/l

1.9

2.0

1.73

2999

25985

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

182

610

3.09

41.80

1.8

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3491

32019

2.60

41.16

27.6

15.5

mmol/l

4.0

7.86

3424

31101

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

581

3277

1.92

40.95

2.0

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

765

4706

1.79

40.83

2.1

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

224

859

2.71

40.20

3.3

3.2

u/ml

0.3

0.4

0.12

127

495

(3004716) Salmonella sp identified in Stool by Organism specific culture

297

1306

2.39

40.01

1.4

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

481

2592

1.98

38.63

1.6

1.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

12.88

38.31

1.9

1.4

pmol/l

154.9

28.9

2.44

(3021447) Carbon dioxide [Partial pressure] in Venous blood

498

2729

1.95

38.07

4.6

3.5

kpa

5.8

5.9

0.19

483

2650

(4010399)

444

2340

2.02

37.94

1.5

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

681

4138

1.79

37.55

1.4

1.3

titre

581.6

559.5

0.10

154

945

(3019060) Gas panel - Arterial blood

389

1966

2.09

37.23

4.6

4.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

469

2537

1.97

37.18

2.5

1.8

nmol/l

356.1

367.2

0.62

418

2281

(40768793) Breast Pathology biopsy report

203

4.52

36.90

1.2

—

(3020891) Body temperature

276

1218

2.37

36.83

4.5

4.6

—

(3002032) Base excess in Venous blood by calculation

489

2725

1.92

35.41

4.7

3.5

mmol/l

1.9

2.0

0.43

400

2242

(3024354) Oxygen [Partial pressure] in Venous blood

427

2274

1.99

35.32

3.9

3.0

kpa

4.5

0.04

413

2199

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

12.70

34.91

7.5

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

369

1893

2.05

33.81

7.0

6.7

mmol/l

24.7

0.01

349

1751

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

511

2930

1.86

33.78

3.6

3.0

ng/l

209.3

204.2

0.09

457

2687

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

334

1660

2.11

33.29

1.6

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

176

658

2.76

33.14

4.5

2.4

g/l

3.6

3.5

0.24

169

622

(3028026) IgM [Mass/volume] in Serum or Plasma

317

1551

2.14

32.90

1.8

1.4

g/l

1.5

1.2

0.97

289

1411

(40760892) CBC W Ordered Manual Differential panel - Blood

906

6145

1.63

32.71

5.3

4.1

—

(3042936) Bacteria identified in Isolate by Culture

628

3873

1.75

32.46

2.3

2.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

401

2168

1.95

31.60

2.4

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

689

4395

1.70

31.42

36.2

27.3

inr

1.4

0.00

617

(3003327) Ova and parasites identified in Stool by Light microscopy

210

888

2.45

30.75

1.8

1.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3481

32402

2.26

30.68

15.8

9.3

u/l

25.6

25.1

0.75

3395

30973

(3021879) Hepatitis B virus core Ab [Presence] in Serum

292

1422

2.14

30.63

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

2795

24451

1.59

30.59

28.9

15.5

14.1

13.7

33.44

2754

23818

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

638

4020

1.71

30.35

1.5

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

272

1301

2.18

29.85

1.1

titre

68.0

182.6

—

(3025941) Bacteria identified in Stool by Culture

311

1568

2.07

29.76

1.5

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

22.13

29.56

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

290

1434

2.11

29.21

10.7

9.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2012

16530

1.48

28.79

2.8

2.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

196

843

2.40

27.64

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

194

840

2.38

26.95

3.7

3.4

—

(36660697) Celiac disease serology panel - Serum

408

2338

1.84

26.71

1.2

—

(3003338) MCHC [Mass/volume]

2835

25137

1.55

26.68

33.6

17.0

g/l

329.7

331.7

23.00

2813

24943

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1475

11544

1.46

26.25

6.0

4.0

—

(3000494) Fungus identified in Specimen by Culture

552

3470

1.69

26.18

1.7

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

264

1316

2.08

25.99

5.7

3.9

mmol/l

24.0

24.3

0.53

232

1169

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3461

32414

2.05

25.63

27.1

14.9

umol/l

80.6

77.1

6.01

3461

32404

(46235355) HIV 1 and 2 tests - Meaningful Use set

495

3048

1.72

25.27

1.7

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

170

714

2.45

25.26

3.4

2.1

91.9

91.5

0.06

159

667

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

145

4.40

25.25

1.1

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

280

1442

2.02

25.21

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

273

1395

2.03

25.12

10.6

8.7

mmol/l

24.6

24.4

0.45

251

1278

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

114

392

2.97

25.08

11.5

5.0

iu/ml

632.0

529.5

0.08

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

145

568

2.62

24.94

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

145

568

2.62

24.94

1.4

1.3

—

(40768800) Prostate Pathology biopsy report

149

4.28

24.40

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

233

1139

2.12

24.13

3.1

1.5

u/ml

83.5

29.1

0.44

217

1081

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

197

901

2.25

24.10

2.4

1.4

g/l

0.0

0.38

174

817

(3024980) IgG subclass 4 [Mass/volume] in Serum

119

429

2.83

24.04

2.0

1.6

g/l

0.7

0.8

0.39

322

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3188

29245

1.65

23.90

7.9

6.2

mmol/mol

41.2

40.3

5.81

2966

26909

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

215

1023

2.17

23.87

2.4

1.5

g/l

0.7

0.5

0.41

181

865

(3009508) Creatinine [Moles/volume] in Urine

1330

10379

1.44

23.24

3.4

3.1

mmol/l

6.8

7.1

2.05

1108

8660

(3036489) Thrombin time

202

949

2.19

23.15

3.1

1.9

22.4

21.0

0.93

182

821

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

110

4.78

23.12

5.2

1.1

u/ml

349.4

101.7

0.54

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

157

663

2.43

23.07

4.1

2.3

196.2

187.4

0.67

149

630

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

300

3.15

22.86

3.8

2.4

u/ml

305.4

608.6

—

(3012516) Albumin [Mass/volume] in Urine

1296

10089

1.44

22.85

3.6

3.2

mg/l

553.3

287.0

0.99

797

6142

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

242

1226

2.04

22.78

2.4

1.4

g/l

7.4

7.5

0.17

173

895

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

230

1144

2.08

22.75

2.4

1.4

g/l

3.2

3.1

0.80

170

878

(3007566) Smooth muscle Ab [Titer] in Serum

173

769

2.31

22.65

1.3

1.2

titre

78.6

180.8

0.68

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

241

1224

2.04

22.53

2.4

1.4

g/l

3.7

3.8

0.49

169

855

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

313

1741

1.87

22.41

3.6

2.9

pmol/l

4.4

4.5

1.06

268

1512

(44790048)

269

3.25

22.25

1.9

1.4

—

(44790049)

269

3.25

22.25

1.9

1.4

—

(44790047)

269

3.25

22.25

1.9

1.4

—

(44806118)

269

3.25

22.25

1.9

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

240

1225

2.03

22.13

2.4

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

182

840

2.23

21.79

2.5

1.4

g/l

0.0

0.00

160

758

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

265

1409

1.95

21.74

4.2

2.6

0.6

0.7

0.24

252

1349

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

179

823

2.23

21.63

2.5

1.4

g/l

0.0

0.00

160

755

(3042111) Morphology [Interpretation] in Bone marrow Narrative

102

360

2.89

21.45

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3283

30506

1.68

21.43

6.0

4.9

mmol/l

6.1

6.0

3.02

3004

27609

(3023487) Leukocytes [#/volume] in Peritoneal fluid

5.70

21.15

3.1

3.0

e6/l

263.0

685.2

0.63

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

4.80

21.02

2.3

2.5

41.6

44.3

0.34

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

215

1077

2.06

20.86

2.0

1.8

ug/l

2.7

1.5

0.96

185

926

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

6.05

20.75

2.9

2.4

e6/l

2359.2

54821.5

0.87

(3029937) Albumin [Presence] in Urine by Test strip

1072

8176

1.44

20.66

6.5

4.2

estimate

0.0

1.08

230

2527

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

265

1434

1.91

20.62

4.2

2.6

1.1

1.2

0.93

265

1423

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

149

649

2.35

20.45

1.4

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

265

3.14

20.13

1.6

1.3

—

(3007461) Platelets [#/volume] in Blood

3523

33519

2.07

20.05

36.5

19.1

e9/l

250.0

250.4

0.12

3466

32500

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

222

1143

2.00

19.97

2.4

1.4

g/l

10.2

10.3

0.14

181

943

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

7.30

19.92

1.2

1.1

—

(3024731) MCV [Entitic volume]

3523

33528

2.06

19.89

36.4

19.0

90.7

91.3

14.42

3484

32933

(3035941) MCH [Entitic mass]

3523

33530

2.06

19.85

36.3

19.0

29.9

30.4

31.57

3484

32936

(3004119) Hemoglobin [Mass/volume] in Venous blood

325

1898

1.78

19.80

4.3

3.1

g/l

122.0

129.9

8.04

317

1842

(3026361) Erythrocytes [#/volume] in Blood

3523

33533

2.06

19.80

36.6

19.1

e12/l

4.4

4.5

23.02

3454

32386

(3010813) Leukocytes [#/volume] in Blood

3523

33536

2.06

19.74

36.6

19.1

e9/l

6.7

0.62

3452

32384

(3000963) Hemoglobin [Mass/volume] in Blood

3523

33540

2.05

19.67

36.8

19.2

g/l

129.9

135.1

78.05

3482

32949

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

739

5288

1.50

19.66

1.3

u/ml

16.7

14.3

0.14

263

2011

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

769

5555

1.49

19.50

1.3

iu/ml

26.8

35.9

1.35

215

1741

(3023183) Ammonium ion [Moles/volume] in Plasma

131

552

2.42

19.38

3.8

2.8

umol/l

36.2

35.3

0.10

115

472

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

185

901

2.11

19.35

3.2

3.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1332

10648

1.39

19.33

4.3

3.9

mg/mmol

12.0

7.7

1.86

809

6524

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

194

964

2.07

19.24

2.4

1.4

g/l

37.2

37.6

0.51

167

799

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3107

28663

1.52

19.03

20.2

11.8

ml/min/173m2

76.1

76.8

0.87

2623

23086

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

233

3.22

18.99

1.7

1.4

—

(40768441) Liver Pathology biopsy report

129

4.07

18.97

1.6

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

254

3.12

18.93

1.6

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

111

438

2.58

18.87

1.3

—

(40768443) Skin Pathology biopsy report

234

1253

1.93

18.79

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

130

556

2.39

18.62

1.7

1.4

—

(3000492) Spirometry study

423

2701

1.64

18.53

1.7

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

110

439

2.55

18.28

1.3

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

104

408

2.59

17.91

1.6

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

314

1875

1.74

17.68

1.3

au/ml

50.8

51.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

333

2072

1.67

16.08

2.5

2.4

au/ml

9.3

22.9

3.45

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

127

574

2.26

16.05

1.7

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

264

2.88

15.94

1.9

1.2

—

(3049717) Cytology report of Urine Cyto stain

177

914

1.98

15.81

2.6

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

936

7249

1.39

15.74

1.9

1.7

pmol/l

11473732.0

36248744.5

1.17

767

5912

(3037756) Immunofixation for Serum or Plasma

124

562

2.25

15.58

1.5

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

353

2.59

15.55

1.1

g/l

1.6

1.5

0.58

303

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3159

29518

1.48

15.41

4.8

4.2

mmol/l

1.3

4.61

2867

26692

(40768795) Lymph node Pathology biopsy report

5.20

15.31

1.3

1.1

—

(3003181) Sodium [Moles/volume] in Urine

121

547

2.25

15.30

1.3

mmol/l

57.7

62.8

0.92

104

437

(3042733) HLA Ab [Presence] in Serum

4.89

15.19

5.8

5.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

5.30

15.12

2.2

1.7

g/l

11.1

13.0

0.39

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

412

2.44

15.12

1.6

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

211

1173

1.85

15.10

1.1

u/ml

0.8

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

292

1785

1.69

15.07

1.6

1.3

u/ml

144.0

229.2

2.64

274

1638

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

110

481

2.33

15.04

1.6

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

359

2.54

15.03

1.6

1.4

u/ml

102.0

112.1

0.35

(3011412) CD3 cells [#/volume] in Blood

163

3.35

14.89

1.8

2.0

e9/l

1.2

1.1

0.54

(3003694) ABO and Rh group [Type] in Blood

880

6803

1.39

14.82

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

178

949

1.92

14.51

3.3

1.5

mg/l

38.6

40.0

0.07

155

759

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

169

888

1.95

14.38

1.6

g/l

1.2

0.26

160

832

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

173

917

1.93

14.35

3.3

1.5

ratio

1.6

2.1

0.34

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

616

4497

1.44

14.34

1.5

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

103

448

2.34

14.28

1.5

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

177

950

1.91

14.14

3.3

1.5

mg/l

57.5

45.3

0.70

154

763

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

166

872

1.95

14.14

1.5

1.6

g/l

0.2

0.10

155

822

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

340

2.54

14.14

1.6

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

165

3.24

13.94

1.3

1.1

u/l

34.4

17.3

1.33

139

(3048929) Epstein Barr virus Ab [Presence] in Serum

121

569

2.16

13.92

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

190

1057

1.84

13.59

1.6

titre

82.9

295.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

282

2.66

13.59

1.8

1.4

g/l

0.4

0.22

197

(3027135) IgG subclass 1 [Mass/volume] in Serum

282

2.66

13.59

1.8

1.4

g/l

6.0

6.9

1.40

195

(3028192) IgG subclass 2 [Mass/volume] in Serum

282

2.66

13.59

1.8

1.4

g/l

2.8

0.01

195

(3017446) Testosterone [Moles/volume] in Serum or Plasma

220

1280

1.76

13.56

2.5

2.2

nmol/l

12.1

14.1

1.19

186

1104

(3026389) Candida sp identified in Specimen by Organism specific culture

417

2.34

13.37

1.5

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

139

702

2.02

13.26

3.4

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

103

464

2.25

13.18

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

162

866

1.91

13.12

1.6

1.5

—

(3044007) Cell count panel - Peritoneal fluid

4.94

13.09

2.9

2.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

162

3.18

13.00

1.1

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

118

3.59

12.95

1.9

2.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

149

779

1.95

12.89

1.1

u/ml

11.7

8.0

0.18

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

10.81

12.86

1.1

1.0

ug/l

1.9

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3310

31429

1.50

12.81

6.2

5.3

mmol/l

2.6

2.7

11.64

3056

28757

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

169

3.11

12.77

2.2

2.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3229

30527

1.45

12.62

5.3

4.7

mmol/l

1.4

1.5

16.84

2963

27879

(3027273) Bicarbonate [Moles/volume] in Venous blood

245

1516

1.66

12.07

3.2

3.0

mmol/l

25.0

25.3

0.86

239

1466

(21494434) Karyotype in Bone marrow

213

2.80

12.05

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

124

3.41

12.04

1.7

2.0

17.5

14.7

0.45

(4062490)

282

2.55

12.04

1.8

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

300

2.50

12.02

1.2

1.1

u/l

56.8

58.1

0.08

200

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

219

2.77

12.01

1.2

titre

336.4

153.4

0.61

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

115

3.51

11.94

1.8

1.7

e9/l

0.3

0.2

0.37

102

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

115

3.51

11.94

1.5

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

115

3.51

11.94

1.5

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

114

557

2.08

11.93

1.7

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

339

2.39

11.82

1.4

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3244

30763

1.44

11.80

5.4

4.7

mmol/l

4.5

4.7

20.44

3006

28290

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

121

3.42

11.77

1.9

1.8

e6/l

529.2

767.0

1.38

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

12.04

11.74

3.4

1.5

pmol/l

39.4

94.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

211

2.78

11.69

1.5

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

211

2.78

11.69

1.5

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

211

2.78

11.69

1.5

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

392

2.28

11.61

1.4

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

210

1262

1.70

11.56

1.4

1.2

u/ml

0.9

0.02

128

(3016038) Potassium [Moles/volume] in Urine

214

2.74

11.39

1.2

1.1

mmol/l

32.2

35.0

0.35

177

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

378

2.28

11.27

1.2

u/ml

334.7

276.6

1.16

230

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

450

2.16

11.20

1.3

nmol/l

0.4

0.3

0.07

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

446

2.16

11.05

1.3

nmol/l

0.6

0.20

428

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

266

1719

1.59

11.00

1.8

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

204

1234

1.69

10.97

1.9

u/l

39.2

38.8

0.09

167

1058

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

358

2.29

10.91

1.5

1.3

—

(3013512) EKG study

1132

9428

1.29

10.82

4.9

4.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

411

2.19

10.79

1.3

—

(40768806) Pleura Pathology biopsy report

178

2.83

10.52

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

120

3.27

10.52

1.8

1.7

e6/l

491.9

425.0

0.49

102

(3010375) cycloSPORINE [Mass/volume] in Blood

106

3.42

10.40

37.0

24.2

ug/l

115.1

110.4

0.14

(3028308) Erythrocytes [#/volume] in Pleural fluid

220

2.62

10.29

1.4

1.5

e6/l

19075.2

62254.9

0.81

132

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

381

2.21

10.23

1.1

1.0

—

(3051651) Icteric interference index of Serum or Plasma

133

3.11

10.16

3.9

4.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

251

2.50

10.16

1.5

e6/l

1404.1

2159.7

0.69

183

(3024471) HLA-A [Type]

4.11

10.14

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

282

2.40

10.10

1.5

g/l

29.7

28.1

0.38

247

(3033799) Differential panel - Peritoneal fluid

4.22

10.08

2.5

2.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

123

657

1.90

10.06

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

277

2.41

10.02

3.7

3.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

444

2.10

10.01

1.2

—

(3024932) HLA-DR beta [Type]

4.15

9.88

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.73

9.86

4.1

2.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.91

9.84

3.9

2.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

134

742

1.84

9.81

1.4

1.7

—

(3045142) Bone marrow Pathology biopsy report

204

2.62

9.64

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

148

2.93

9.64

1.9

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

435

3196

1.41

9.57

1.6

—

(1761868) Lipid panel - Serum or Plasma

829

10070

0.77

9.47

3.4

3.1

—

(4281824)

183

2.70

9.46

1.2

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

414

2.10

9.44

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

119

3.13

9.32

9.4

6.9

mg/l

125.3

62.3

0.48

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

278

1884

1.51

9.31

1.3

1.2

iu/ml

91.3

140.2

2.46

105

714

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

129

718

1.83

9.30

1.2

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

329

2310

1.47

9.26

4.9

3.7

1.1

0.7

1.72

471

(3009214) Lutropin [Units/volume] in Serum or Plasma

411

2.09

9.23

1.3

u/l

13.6

11.0

0.75

326

(3045788) Cell count panel - Pleural fluid

203

2.58

9.22

1.4

1.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

180

2.69

9.21

1.3

u/l

215.2

267.8

0.57

171

(3016650) Hepatitis A virus Ab [Presence] in Serum

367

2.15

9.09

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

152

897

1.72

9.00

1.5

1.6

iu/ml

0.1

3.4

0.51

189

(3017732) Neutrophils [#/volume] in Blood

295

2039

1.49

8.99

3.1

2.9

e9/l

4.2

4.1

0.48

208

1491

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

431

2.04

8.87

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

128

723

1.80

8.82

1.5

1.3

—

(3024928) Oxygen saturation in Venous blood

112

610

1.86

8.68

6.4

3.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

265

2.32

8.62

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.38

8.52

2.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

194

2.55

8.47

1.1

1.0

nmol/l

9.9

8.7

0.06

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

4.65

8.34

1.2

1.1

ug/l

100.6

73.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

114

635

1.82

8.24

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

282

2.22

7.90

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

129

756

1.73

7.87

2.0

mg/l

12.4

11.6

0.64

122

688

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

355

2.08

7.87

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

239

2.32

7.81

2.8

2.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

351

2.07

7.71

1.3

—

(3023419) Bacteria identified in Sputum by Culture

385

2.02

7.71

3.4

2.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

168

2.58

7.67

1.9

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

359

2.05

7.65

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

261

2.24

7.60

1.4

u/l

33.1

34.9

0.14

190

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

175

2.53

7.57

1.2

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

114

653

1.77

7.55

4.5

2.7

mg/l

1.9

1.6

1.83

106

579

(3000093) Morphology [Interpretation] in Blood Narrative

256

2.25

7.51

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

3.31

7.51

1.9

1.8

160.3

181.6

0.66

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

136

2.74

7.43

2.2

2.4

u/ml

955.9

901.6

0.09

136

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

207

2.39

7.43

1.1

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

351

2.04

7.35

1.4

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

136

826

1.67

7.31

2.7

2.3

ug/min

129.0

88.3

0.46

486

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

266

2.20

7.28

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

366

2.01

7.27

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

500

1.86

7.24

1.6

1.2

u/l

43.8

22.7

1.14

429

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

179

2.48

7.24

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

235

2.27

7.21

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

354

2.03

7.19

1.4

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

327

2.07

7.18

7.9

6.7

mg/l

12.6

12.1

0.42

302

(4094501)

145

903

1.63

7.08

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

182

2.43

7.00

1.3

1.6

u/l

6.1

6.0

0.05

156

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

176

2.46

6.99

1.8

1.4

u/l

5.6

5.5

0.02

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

113

2.85

6.94

1.9

1.7

139.2

149.9

0.40

107

(3036782) Glucose [Moles/volume] in Pleural fluid

196

2.36

6.87

1.4

1.3

mmol/l

6.5

7.1

0.65

179

(3039000) Anion gap in Blood

110

642

1.74

6.86

6.4

6.9

mmol/l

11.1

11.2

0.20

100

573

(3018572) Chloride [Moles/volume] in Blood

110

642

1.74

6.86

6.4

6.9

mmol/l

105.2

104.8

0.46

100

573

(3006922) Hepatitis E virus Ab [Presence] in Serum

166

2.49

6.83

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

396

1.94

6.81

1.2

1.3

nmol/l

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

526

1.81

6.77

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

150

953

1.60

6.76

3.4

2.6

g/l

0.4

0.3

0.38

301

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

188

1258

1.52

6.75

4.7

4.8

1.6

0.06

177

1180

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

163

1057

1.57

6.74

2.2

ug/l

386.5

748.7

0.96

154

990

(3007930) Methemoglobin/Hemoglobin.total in Blood

185

1238

1.52

6.64

4.8

4.9

0.9

0.30

172

1163

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

353

1.97

6.54

1.8

u/l

6460.8

2316.1

0.43

138

(3017704) Immunofixation for Urine

158

2.48

6.50

1.7

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.34

6.49

1.4

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

227

2.22

6.47

1.0

mg/l

290.7

291.8

0.04

200

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.56

6.45

7.7

10.0

mmol/l

4.9

5.4

0.39

(3016750) Collection duration of Urine

178

2.38

6.37

2.7

2.1

min

497.8

502.0

0.12

132

(3000060) B lymphocytes [#/volume] in Blood

4.22

6.28

1.6

1.9

e6/l

44.3

130.9

—

(3012441) Differential panel - Pleural fluid

211

2.24

6.26

1.4

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

338

1.97

6.25

4.1

2.9

1.3

1.2

0.02

250

(3047181) Lactate [Moles/volume] in Blood

143

919

1.58

6.18

6.1

6.0

mmol/l

1.4

1.3

0.21

126

808

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

962

8290

1.22

6.14

5.7

3.9

ug/l

3.1

2.5

0.43

868

7393

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

194

2.28

6.12

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

5.80

6.10

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

128

2.59

6.03

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

128

2.59

6.03

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

384

2974

1.32

6.02

3.6

3.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

152

2.45

6.02

1.5

1.2

—

(3004775) Volume in Urine collected for unspecified duration

261

2.08

6.00

2.9

2.4

706.2

618.4

1.07

172

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

101

599

1.71

5.99

2.5

1.6

nmol/l

0.9

0.8

0.43

493

(40768446) Kidney Pathology biopsy report

100

2.81

5.99

1.8

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

196

2.26

5.98

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

792

6709

1.23

5.96

5.1

3.8

22.6

24.2

2.57

437

3240

(44816559) Phosphatidylethanol [Mass/volume] in Blood

466

1.80

5.96

1.4

1.3

—

(3045414) Leukocytes [Presence] in Urine

207

1453

1.45

5.90

2.0

1.9

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

130

2.55

5.86

1.4

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

149

2.43

5.77

1.1

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.61

5.75

1.7

1.6

g/l

20.3

24.7

0.37

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

374

2905

1.32

5.75

1.7

1.5

0.08

311

2514

(3025159) Blasts/100 leukocytes in Blood

286

2137

1.37

5.70

4.8

3.8

0.0

0.3

0.65

387

(3035880) pH of Pleural fluid

115

2.62

5.63

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

5.90

5.62

2.0

1.3

umol/24h

372.4

316.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

296

2231

1.36

5.58

4.9

3.7

0.1

0.30

440

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.82

5.53

3.0

2.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

397

1.83

5.51

1.3

1.2

u/ml

5.1

3.3

0.26

126

(3011985) Renin [Units/volume] in Plasma

421

1.80

5.42

1.5

1.3

mu/l

39.5

64.2

1.13

378

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

155

2.34

5.32

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

155

2.34

5.32

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

148

994

1.51

5.29

1.5

1.8

—

(3010503) CD19 cells [#/volume] in Blood

102

2.66

5.23

2.1

2.0

e9/l

0.2

0.1

0.25

(21494755) Public health laboratory ask at order entry panel

130

1938

0.66

5.20

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

391

1.81

5.16

1.3

1.2

u/ml

6.7

5.5

0.25

166

(3002179) Metamyelocytes/100 leukocytes in Blood

282

2138

1.35

5.14

4.1

3.6

0.7

0.5

0.43

358

(3023323) Follitropin [Units/volume] in Serum or Plasma

128

840

1.54

5.11

1.3

iu/l

36.1

33.6

0.35

110

735

(40757373) Influenza virus identified in Isolate

3.18

5.03

1.4

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

198

2.13

5.03

2.0

2.6

—

(4034850)

1120

0.56

5.02

20.7

9.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

251

1877

1.36

5.00

3.8

3.5

kpa

5.0

5.2

2.22

232

1719

(3000475) Leukocytes [#/volume] in Synovial fluid

130

861

1.53

4.98

1.8

1.6

e6/l

10526.5

11007.2

0.08

630

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

561

4664

1.24

4.98

3.2

2.7

ug/l

0.8

0.7

0.61

419

3180

(3009343) pH of Capillary blood

247

1849

1.36

4.90

3.8

3.5

7.4

0.27

230

(3022313) Gas panel - Capillary blood

187

1337

1.42

4.88

3.8

3.6

—

(40765096) Chromosome analysis panel by Banding

3.79

4.81

1.4

1.0

—

(3008295) Osmolality of Serum or Plasma

292

1.90

4.78

1.3

1.4

mosm/kgh2o

278.2

276.8

0.13

216

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.80

4.71

1.4

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

238

1785

1.36

4.67

3.7

3.4

mmol/l

1.5

2.0

1.47

184

1327

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

389

1.76

4.66

2.3

2.2

mg/l

29.1

25.0

0.20

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

100

639

1.58

4.52

1.3

1.2

mmol/l

3.8

3.9

0.70

593

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

167

2.17

4.52

1.1

1.0

iu/ml

6.0

12.7

—

(3044927) Protein electrophoresis panel - Urine

356

1.78

4.52

1.2

—

(3036603) Volume of Urine

182

2.10

4.41

1.6

1.4

1977.9

1840.1

0.22

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

344

1.79

4.41

1.1

u/ml

6.7

2.8

0.37

137

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

137

2.27

4.37

1.1

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.72

4.36

1.5

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

224

1.98

4.35

1.8

1.3

u/ml

0.5

1.2

0.54

108

(3020393) Adenovirus Ag [Presence] in Stool

4.56

4.30

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.79

4.28

1.6

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

393

1.72

4.25

1.3

pmol/l

259.2

294.9

0.62

298

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

107

709

1.52

4.15

2.1

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

279

1.84

4.09

3.5

3.9

—

(44813793)

195

2.01

4.07

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

143

2.18

3.98

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

564

1.57

3.97

1.9

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.82

3.95

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

109

734

1.50

3.94

3.6

3.2

nmol/l

0.8

1.66

571

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

171

2.06

3.90

2.2

2.1

ug/min

258.0

139.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

262

1.84

3.89

1.8

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

100

2.41

3.88

4.5

2.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

220

1.92

3.86

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

145

2.15

3.86

1.4

1.2

—

(3019225) pH of Specimen

386

3169

1.24

3.85

5.0

3.6

—

(3006270) Folate [Moles/volume] in Blood

307

1.77

3.85

1.4

1.2

nmol/l

365.8

355.5

0.08

260

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

553

1.57

3.84

1.3

1.2

miu/ml

187.4

219.6

0.32

247

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

214

1.93

3.81

1.3

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

236

1.87

3.78

1.2

1.1

—

(3021788) Differential panel - Synovial fluid

628

1.53

3.76

1.6

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.80

3.68

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

224

1.89

3.68

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

224

1.89

3.68

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

224

1.89

3.68

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

395

1.66

3.67

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.61

3.63

1.1

75.0

91.1

—

(3006653) Thiamine [Moles/volume] in Blood

156

2.06

3.61

1.6

1.2

nmol/l

137.8

0.00

156

(3032773) Endomysium IgG Ab [Titer] in Serum

226

1.87

3.59

1.0

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

159

1172

1.37

3.56

3.9

3.8

mmol/l

24.9

25.0

0.06

143

1067

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.58

3.54

1.0

1.1

91.0

88.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

637

1.50

3.54

1.2

—

260.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

220

1.87

3.54

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

220

1.87

3.54

1.1

—

(3047189) Immunofixation for 24 hour Urine

105

2.29

3.52

1.7

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

672

1.49

3.49

2.4

2.1

g/l

122.5

130.1

1.76

490

(4306422)

394

1.64

3.45

1.3

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

563

1.52

3.37

1.3

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.10

3.37

1.2

1.3

nmol/l

5.1

760005.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.71

3.35

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

154

2.02

3.34

5.3

3.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.25

3.34

8.3

3.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

972

8766

1.15

3.31

1.7

mmol/l

1.4

0.54

830

7269

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

384

1.63

3.28

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

116

2.16

3.22

1.2

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

676

1.46

3.21

1.4

1.2

u/ml

10.2

5.7

—

(4211845)

171

1.94

3.18

5.0

3.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.96

3.13

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

129

941

1.38

3.12

1.5

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

631

1.47

3.11

1.3

e6/l

49.1

26.8

0.23

484

(3035947) Staphylolysin Ab [Units/volume] in Serum

138

2.04

3.10

1.2

1.1

iu/ml

—

4.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

632

1.47

3.09

1.4

e6/l

1980.8

1360.2

0.12

514

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.45

3.04

1.0

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.45

3.04

1.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

232

1.78

3.03

4.6

2.8

61.8

58.4

0.42

149

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

2.90

3.02

1.4

1.5

15.6

30.0

—

(40762887) Creatinine [Moles/volume] in Blood

10.01

2.98

1.4

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

2.64

2.96

1.5

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

264

1.71

2.95

1.2

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.55

2.95

1.9

2.3

—

(3045424) Erythrocytes [Presence] in Urine

532

1.50

2.95

1.9

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.70

2.88

2.0

2.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.39

2.87

1.1

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

5.39

2.87

2.3

1.0

nmol/l

58.3

4.1

—

(3009871) Measles virus Ab [Titer] in Serum

2.25

2.86

1.4

1.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.93

2.85

1.2

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

208

1.79

2.82

1.9

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.77

2.81

1.4

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

338

1.61

2.79

1.1

u/ml

4.5

3.6

0.18

165

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

231

1.74

2.79

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

8.34

2.75

1.0

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.15

2.70

1.3

1.4

ug/l

11.8

8.8

1.38

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

139

1.95

2.69

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.33

2.65

1.1

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

134

1.95

2.60

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.90

2.58

1.4

1.2

ug/l

2.2

36.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.30

2.57

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

246

1.67

2.52

5.1

3.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

108

2.04

2.51

1.0

—

(3025315) Body weight

3.82

2.46

4.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.01

2.40

2.0

2.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

689

0.63

2.39

3.1

3.7

mg/l

23.7

26.5

0.25

431

(3044941) Cell count panel - Synovial fluid

549

1.43

2.39

1.6

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

101

744

1.37

2.38

3.6

3.1

mmol/l

23.8

25.1

2.69

657

(3004451) EKG impression Narrative

153

1.84

2.38

1.3

—

(3012501) Base excess in Blood by calculation

618

1.40

2.35

4.0

4.2

mmol/l

2.7

2.6

0.13

419

(3000012) Reticulocyte production index

161

1.81

2.35

1.3

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.22

2.30

1.8

2.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

105

2.01

2.30

1.3

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.46

2.27

2.2

1.6

—

(3022689) Creatine [Moles/volume] in Urine

106

1.99

2.25

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

108

812

1.34

2.25

5.4

4.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

334

1.53

2.24

1.4

1.3

e6/l

150188.4

130346.8

0.05

232

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.11

2.22

1.9

2.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

558

1.41

2.21

3.8

2.9

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

272

1.59

2.20

1.3

1.1

—

67.8

—

(1616796) Gas panel - Central venous blood

618

1.38

2.19

3.8

3.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.34

2.18

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.24

2.17

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

158

1.78

2.17

1.4

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

281

1.57

2.16

1.3

1.2

—

73.0

—

(3000330) Specific gravity of Urine by Test strip

203

1667

1.23

2.13

4.5

3.4

—

(3042631) Mycobacterium sp identified in Specimen

347

1.51

2.11

2.2

3.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

107

812

1.33

2.11

1.4

1.2

u/ml

1.8

5.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

167

1.74

2.11

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

389

1.47

2.08

1.0

1.1

—

(3048879) Bone marrow aspiration report

2.26

2.07

1.4

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.01

2.07

5.2

4.7

umol/l

411.0

370.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

3.50

2.05

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

110

1.91

2.05

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.00

2.04

1.0

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

254

1.58

2.03

1.3

1.1

—

4.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

107

820

1.31

1.99

1.4

1.3

u/ml

1.8

5.3

1.98

145

(3023410) Appearance of Cerebral spinal fluid

264

1.56

1.97

1.4

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

743

1.33

1.97

1.9

1.8

iu/l

152.3

4.8

0.50

246

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

495

1.40

1.96

3.2

3.6

60.9

57.7

1.26

495

(3008401) Mugwort IgE Ab [Units/volume] in Serum

332

1.48

1.88

1.1

u/ml

0.8

1.0

0.16

136

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.86

1.86

1.3

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.86

1.86

1.3

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.86

1.86

1.3

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.09

1.86

1.8

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

342

1.47

1.84

1.3

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.21

1.84

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.53

1.83

1.0

1.1

—

(4027681)

137

1.76

1.83

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

206

1.61

1.82

1.8

1.4

nmol/l

0.2

0.3

0.97

162

(3028707) Methadone [Presence] in Urine by Screen method

191

1.63

1.80

1.3

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.05

1.80

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.05

1.80

1.1

1.3

—

(3000285) Sodium [Moles/volume] in Blood

2.34

1.77

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

173

2082

0.82

1.75

2.0

1.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

619

1.33

1.73

2.9

2.7

kpa

8.3

8.0

1.02

571

(3028679) Herpes simplex virus Ab [Presence] in Serum

110

1.82

1.72

1.3

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.67

1.72

1.1

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.92

1.72

1.4

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

433

1.39

1.68

1.5

63.3

59.9

0.29

271

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

227

1.55

1.67

1.5

—

(3010421) pH of Blood

737

1.30

1.67

4.1

4.0

7.4

0.03

604

(3028433) Virus identified in Specimen by Culture

1.89

1.65

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

158

1.65

1.62

1.5

1.9

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.87

1.60

1.1

1.2

ug/l

3.9

2.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.33

1.60

1.2

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

170

1418

1.21

1.60

1.8

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.43

1.53

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

151

1252

1.21

1.52

1.6

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

374

1.40

1.52

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.60

1.51

1.3

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.86

1.50

1.7

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.90

1.49

5.0

7.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

186

1.56

1.48

1.3

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

419

1.37

1.47

1.5

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.81

1.47

1.4

36.3

31.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

394

1.38

1.46

1.1

u/ml

1.1

1.7

0.30

154

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.45

1.6

2.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

148

1.63

1.44

1.3

1.2

ratio

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.92

1.43

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.86

1.40

1.3

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.90

1.39

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.00

1.38

1.3

1.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

174

1.56

1.37

1.1

1.2

—

(4212803)

2.61

1.36

1.0

—

(3011288) Drugs identified in Urine by Screen method

281

1.43

1.35

1.5

2.2

—

(3021901) Oxygen saturation in Capillary blood

530

1.31

1.35

3.1

2.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

215

1.49

1.35

1.2

mmol/l

1.9

2.1

0.65

201

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.87

1.34

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

136

1134

1.21

1.33

1.6

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.04

1.32

1.3

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.36

1.29

2.5

1.6

umol/l

48.6

46.9

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.36

1.29

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.78

1.28

1.8

2.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

276

1.42

1.28

1.1

—

52.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.29

1.26

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

155

1.55

1.22

1.1

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.63

1.21

1.0

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.16

1.21

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.80

1.21

1.2

1.1

—

(3014271) Vancomycin [Susceptibility]

180

1.50

1.20

3.8

3.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.75

1.18

1.7

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.75

1.18

1.7

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.31

1.18

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.31

1.18

1.0

—

(3028271) Lactate [Moles/volume] in Capillary blood

454

1.30

1.18

2.0

1.8

mmol/l

1.8

1.7

0.28

442

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

1.1

—

10.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.50

1.15

1.0

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

1.81

1.15

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

626

1.25

1.13

1.5

1.2

u/ml

15.9

45.3

—

(3016879) Cocaine [Presence] in Urine

405

1.31

1.12

1.3

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

111

1.62

1.12

1.1

1.2

g/l

35.3

38.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

531

1.27

1.09

1.6

1.8

nmol/l

40.0

43.7

0.89

504

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.95

1.08

1.4

1.0

—

(3024263) Appearance of Synovial fluid

186

1.45

1.05

1.6

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

322

1.34

1.05

1.3

1.5

31.3

30.8

0.03

204

(4268621)

279

1.37

1.05

2.2

2.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

170

1.47

1.04

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.27

1.03

1.6

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

447

1.28

1.02

1.9

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

290

1.35

1.01

1.1

—

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.65

1.00

1.1

—

(3008898) HLA-B27 [Presence]

105

883

1.19

1.00

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.00

1.00

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.71

0.98

1.1

1.2

umol/24h

0.8

0.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

135

0.52

0.98

2.3

5.3

—

60.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

831

1.20

0.97

1.4

1.8

—

(3014891) Appearance of Pleural fluid

1.95

0.97

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

116

1.55

0.96

1.3

2.4

umol/l

88.0

139.7

0.58

(3027944) Amphetamines [Presence] in Urine

434

1.27

0.95

1.3

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.77

0.94

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.67

0.91

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

143

1.47

0.89

1.3

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.07

0.89

1.2

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.91

0.88

1.4

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

2.00

0.87

1.2

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.00

0.87

1.3

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

2.00

0.87

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

814

7751

1.06

0.85

4.6

3.4

—

(3051593) INR in Capillary blood by Coagulation assay

170

1.41

0.85

21.1

11.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

137

1.46

0.84

1.1

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

137

1.46

0.84

1.1

1.3

—

(3025130) Human papilloma virus identified in Specimen

318

1.29

0.83

1.6

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.76

0.83

1.0

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

120

1377

0.87

0.81

1.6

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.70

0.80

1.3

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

199

1792

1.12

0.79

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

242

1.33

0.78

1.1

—

(3027008) Opiates [Presence] in Urine

438

1.24

0.78

1.3

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

127

1113

1.15

0.78

2.0

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

148

1.42

0.77

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

439

1.23

0.77

1.3

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

107

1.50

0.76

1.8

1.6

ug/l

0.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

136

1201

1.14

0.75

2.2

1.7

—

(3034426) Prothrombin time (PT)

1.52

0.75

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

1.70

0.75

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.57

0.74

2.2

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

378

1.25

0.74

3.0

2.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

201

1.35

0.74

1.3

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.84

0.73

1.0

1.3

—

(3028300) Cannabinoids [Presence] in Urine

442

1.23

0.73

1.3

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.80

0.72

1.0

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

142

1.41

0.72

1.2

1.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.75

0.71

1.1

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

112

981

1.15

0.71

1.9

1.6

mg/l

8.3

3.7

1.21

699

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.92

0.70

1.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.71

0.70

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.71

0.70

1.1

1.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

267

2463

1.09

0.68

4.6

3.0

mmol/l

1.2

1.34

239

2070

(3039443) Prostate specific Ag panel - Serum or Plasma

397

0.78

0.68

1.7

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

214

1.31

0.66

1.4

1.5

promille

0.6

1.2

1.24

164

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

154

1.37

0.65

2.6

2.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.73

0.64

1.2

1.0

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.73

0.64

1.8

1.6

—

(3015183) Erythrocyte sedimentation rate

112

1.43

0.63

1.1

1.2

—

(1002224) Polysomnography panel

120

1068

1.13

0.62

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.55

0.62

4.8

7.4

—

(3035933) Granulocytes/100 leukocytes in Blood

1.57

0.60

1.5

2.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

105

1.43

0.60

1.1

miu/ml

1977.8

1692.6

0.37

105

(3011648) Oxygen content in Venous blood

227

1.28

0.59

2.2

2.1

10.9

11.0

0.04

227

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.58

0.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

613

1.16

0.58

3.0

2.4

16.4

16.3

0.03

323

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

173

0.69

0.57

1.8

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

173

0.69

0.57

1.8

1.4

—

(3002619) Bacteria identified in Specimen by Culture

1.48

0.57

1.1

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

172

0.70

0.56

1.8

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

172

0.70

0.56

1.8

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.62

0.55

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.54

0.55

1.0

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

294

1.23

0.54

1.1

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.54

0.53

2.3

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.50

0.51

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

109

980

1.12

0.51

1.4

—

(4146454)

379

1.19

0.51

3.0

2.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.39

0.50

1.0

1.2

—

(4015189)

110

1.37

0.48

5.3

2.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

143

0.70

0.47

1.8

1.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

111

1.35

0.46

1.5

1.3

—

(3005033) Fetal Nuchal fold Thickness US

142

0.70

0.46

1.8

1.4

—

(40761536) Microorganisms panel - Urine sediment

226

2410

0.93

0.45

5.6

4.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

112

1.34

0.44

1.7

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

112

1.34

0.44

1.7

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

112

1.34

0.44

1.7

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

112

1.34

0.44

1.7

1.2

—

(4024509)

340

0.82

0.44

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

266

1.20

0.43

1.1

1.0

ng/l

752.7

712.9

0.19

166

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

266

1.20

0.43

1.1

1.0

ng/l

380.9

351.8

0.19

175

(3010726) Horse dander IgE Ab [Units/volume] in Serum

303

1.19

0.43

1.1

u/ml

1.4

2.6

0.43

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.64

0.42

1.0

1.4

—

1497021.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.56

0.42

1.2

—

(3017569) Oxygen content in Arterial blood

158

1.27

0.41

2.6

1.9

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.52

0.41

1.0

1.1

u/ml

0.0

3.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.36

0.41

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

7.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.47

0.40

2.2

2.6

u/field

0.4

0.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

269

1.19

0.39

1.1

1.0

ng/l

46.6

46.9

0.01

171

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.34

0.39

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

148

0.74

0.38

1.7

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.39

0.38

2.0

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

136

0.73

0.37

12.1

11.5

nmol/l

949.4

843.3

—

127

(3000034) Microalbumin [Mass/volume] in Urine

336

1.16

0.37

4.7

2.9

mg/l

155.7

23.8

1.16

245

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.35

0.37

1.2

umol/24h

1.8

1.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

153

1.24

0.35

1.6

1.8

u/field

4.7

2.0

—

104

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

200

1.20

0.33

1.3

1.2

mmol/l

9.6

11.9

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

164

1.22

0.32

1.5

1.3

—

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.30

0.30

1.3

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

372

1.13

0.30

2.0

1.8

89.8

89.6

0.09

366

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

139

1.22

0.29

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

103

1.26

0.28

1.9

1.8

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.21

0.26

1.0

1.1

—

(3019977) pH of Arterial blood

159

1.20

0.26

3.0

2.3

7.4

0.31

(3020650) Glucose [Presence] in Urine

1.30

0.26

1.3

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

123

1.22

0.25

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

181

0.83

0.25

1.7

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

283

1.13

0.24

1.7

u/ml

36.0

22.4

—

(3022621) pH of Urine by Test strip

220

2111

1.04

0.24

4.3

3.1

—

(3020491) Glucose [Moles/volume] in Blood

227

1.15

0.23

2.3

2.4

mmol/l

7.4

6.7

0.72

145

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.74

0.22

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

114

1204

0.95

0.22

1.6

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

135

0.81

0.22

1.6

1.5

—

(44806420)

107

1.22

0.21

2.1

2.3

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.21

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.4

—

2.7

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.16

0.21

1.0

1.2

—

6.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

173

1.16

0.20

1.3

1.4

nmol/l

1.5

1.2

0.61

134

(3023430) Cat dander IgE Ab [Units/volume] in Serum

249

1.13

0.20

1.0

1.1

u/ml

0.8

3.1

1.71

103

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.20

0.0

1.5

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

153

0.85

0.18

2.8

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.21

0.17

1.0

1.2

—

32.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.76

0.17

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.75

0.17

1.0

1.2

—

(4133840)

0.73

0.17

1.4

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.15

0.15

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.13

0.15

2.4

1.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

112

1.16

0.14

1.2

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

266

1.09

0.14

1.8

2.2

u/field

4.0

2.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

413

1.07

0.13

4.9

4.8

umol/l

364.4

362.8

0.03

352

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

219

1.10

0.12

1.1

u/ml

0.1

0.3

0.86

(3014051) Protein [Presence] in Urine by Test strip

749

1.04

0.11

2.1

2.2

—

(3045716) Anion gap in Serum or Plasma

153

1.11

0.11

1.5

2.0

mmol/l

8.1

9.6

—

117

(3034891) Synovial lining cells/100 cells in Synovial fluid

165

1.09

0.08

1.3

1.5

8.2

4.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.07

0.08

7.8

7.7

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.05

0.08

1.3

2.9

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.03

0.08

3.0

2.7

—

64.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

421

4162

1.01

0.08

5.0

4.9

32.6

33.3

0.71

269

2732

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.84

0.07

2.7

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.84

0.07

2.7

2.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.83

0.07

1.1

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

304

1.05

0.07

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.03

0.07

2.8

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

306

1.05

0.05

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

270

1.04

0.03

1.1

u/ml

5.7

2.6

0.37

108

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

439

1.03

0.03

1.2

1.1

iu/ml

67.3

1902.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

138

0.94

0.02

3.0

4.7

—

(3005570) Glucose [Moles/volume] in Urine

329

0.97

0.02

3.5

2.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

192

1.04

0.02

1.8

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

142

0.99

0.00

1.5

pmol/l

176.8

275.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

295

1.02

0.00

3.1

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

141

0.99

0.00

1.2

1.1

u/l

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

367

1.01

0.00

1.3

1.2

mmol/l

7.6

7.7

0.13

263

(3022229) Phosphate [Moles/volume] in Urine

0.00

0.0

1.0

—

16.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1273.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

129.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.98

0.00

1.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

1.8

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

153.2

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.3

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.3

—

147.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.97

0.00

1.7

1.6

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.99

0.00

1.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.99

0.00

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.00

0.00

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.99

0.00

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.99

0.00

1.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_STOMACH_EXALLC – Benign neoplasm: Stomach

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign neoplasm: Stomach

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints